Palvella Therapeutics (PVLA) Retained Earnings (2016 - 2024)
Historic Retained Earnings for Palvella Therapeutics (PVLA) over the last 12 years, with Q3 2024 value amounting to -$326.3 million.
- Palvella Therapeutics' Retained Earnings fell 513.31% to -$326.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$326.3 million, marking a year-over-year decrease of 513.31%. This contributed to the annual value of -$76.3 million for FY2023, which is 7372.75% up from last year.
- As of Q3 2024, Palvella Therapeutics' Retained Earnings stood at -$326.3 million, which was down 513.31% from -$323.4 million recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Retained Earnings ranged from a high of -$76.3 million in Q4 2023 and a low of -$326.3 million during Q3 2024
- For the 5-year period, Palvella Therapeutics' Retained Earnings averaged around -$252.0 million, with its median value being -$262.2 million (2022).
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 2647.56% in 2021, then skyrocketed by 7372.75% in 2023.
- Over the past 5 years, Palvella Therapeutics' Retained Earnings (Quarter) stood at -$211.4 million in 2020, then dropped by 21.64% to -$257.1 million in 2021, then dropped by 12.94% to -$290.4 million in 2022, then skyrocketed by 73.73% to -$76.3 million in 2023, then crashed by 327.69% to -$326.3 million in 2024.
- Its Retained Earnings was -$326.3 million in Q3 2024, compared to -$323.4 million in Q2 2024 and -$319.9 million in Q1 2024.